Income Statement (TTM)
Marinomed Biotech AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 8 | 9 | 9 | 9 | 12 | 12 | 13 | 13 | 12 | 13 | 12 | 12 | 9 | 7 | 7 | 6 | 5 |
| Change (%) | 1.30 | 14.81 | -2.91 | -3.08 | 32.47 | 1.67 | 12.61 | -2.29 | -9.72 | 7.73 | -4.57 | -2.21 | -20.38 | -26.33 | -1.92 | -13.18 | -18.71 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 8 | 9 | 11 | 11 | 10 | 10 | 10 | 10 | 9 | 9 | 10 | 10 | 10 | 8 | 6 | 6 | 5 | 4 |
| Change (%) | 13.37 | 18.16 | 3.36 | -3.66 | -0.63 | -6.26 | 2.21 | -8.69 | 2.98 | 10.08 | -4.69 | -0.71 | -17.47 | -23.36 | -8.35 | -17.39 | -19.62 | |
| % of Revenue | 98.08 | 109.77 | 112.97 | 120.27 | 119.55 | 89.68 | 82.68 | 75.05 | 70.13 | 80.00 | 81.75 | 81.65 | 82.91 | 85.93 | 89.40 | 83.54 | 79.49 | 78.60 |
| Gross Operating Profit | 0 | -1 | -1 | -2 | -2 | 1 | 2 | 3 | 4 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -615.45 | 52.39 | 51.74 | -6.52 | -169.94 | 70.60 | 62.24 | 16.96 | -39.55 | -1.67 | -4.06 | -8.92 | -34.49 | -44.50 | 52.35 | 8.19 | -15.18 | |
| % of Revenue | 1.92 | -9.77 | -12.97 | -20.27 | -19.55 | 10.32 | 17.32 | 24.95 | 29.87 | 20.00 | 18.25 | 18.35 | 17.09 | 14.07 | 10.60 | 16.46 | 20.51 | 21.40 |
| SG&A | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Change (%) | 0.80 | 3.62 | 7.87 | -4.25 | 3.24 | 0.28 | 0.63 | 4.60 | 0.66 | 1.76 | 1.19 | 2.03 | -6.32 | 5.93 | -0.21 | -5.09 | -4.23 | |
| % of Revenue | 54.05 | 53.78 | 48.54 | 53.92 | 53.27 | 41.52 | 40.95 | 36.60 | 39.18 | 43.68 | 41.26 | 43.75 | 45.65 | 53.72 | 77.24 | 78.59 | 85.92 | 101.22 |
| R&D | ||||||||||||||||||
| Change (%) | ||||||||||||||||||
| % of Revenue | ||||||||||||||||||
| OpEx | 14 | 15 | 17 | 17 | 16 | 17 | 17 | 18 | 17 | 17 | 18 | 18 | 17 | 15 | 14 | 13 | 13 | 12 |
| Change (%) | 7.18 | 9.65 | 2.76 | -6.68 | 8.87 | -1.03 | 3.43 | -2.22 | -1.60 | 6.05 | -3.08 | -0.97 | -11.08 | -12.35 | -3.87 | -2.83 | -6.60 | |
| % of Revenue | 175.68 | 185.88 | 177.52 | 187.88 | 180.89 | 148.67 | 144.72 | 132.92 | 133.02 | 144.99 | 142.74 | 144.97 | 146.82 | 163.97 | 195.10 | 191.22 | 214.01 | 245.90 |
| Operating Income | -6 | -7 | -7 | -8 | -7 | -6 | -5 | -4 | -4 | -5 | -5 | -5 | -6 | -6 | -7 | -6 | -7 | -7 |
| Change (%) | 14.95 | 3.63 | 10.07 | -10.78 | -20.31 | -6.58 | -17.09 | -2.01 | 23.01 | 2.34 | 0.41 | 1.80 | 8.80 | 9.51 | -5.92 | 8.51 | 4.02 | |
| % of Revenue | -75.68 | -85.88 | -77.52 | -87.88 | -80.89 | -48.67 | -44.72 | -32.92 | -33.02 | -44.99 | -42.74 | -44.97 | -46.82 | -63.97 | -95.10 | -91.22 | -114.01 | -145.90 |
| Interest Expense | -0 | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -2 | -3 | -3 | -3 | -2 | -1 | -2 | -3 | -1 | -1 |
| Change (%) | 143.05 | 25.98 | 22.25 | 20.66 | 13.80 | 16.08 | 13.34 | 20.35 | 4.97 | 2.87 | -0.34 | -6.42 | -42.57 | 79.89 | 27.84 | -58.62 | -27.01 | |
| % of Revenue | -3.66 | -8.78 | -9.64 | -12.14 | -15.11 | -12.98 | -14.82 | -14.91 | -18.37 | -21.36 | -20.40 | -21.30 | -20.39 | -14.70 | -35.90 | -46.80 | -22.31 | -20.03 |
| Net Income | -6 | -6 | -7 | -7 | -8 | -6 | -6 | -5 | -5 | -6 | -7 | -6 | -6 | -6 | -7 | -14 | -14 | -15 |
| Change (%) | 2.73 | 8.67 | 9.61 | 5.14 | -21.73 | -4.38 | -4.97 | 0.45 | 18.98 | 3.47 | -8.31 | 2.36 | 2.46 | 7.85 | 105.64 | -1.63 | 11.01 | |
| % of Revenue | -72.94 | -73.98 | -70.02 | -79.05 | -85.75 | -50.67 | -47.65 | -40.21 | -41.34 | -54.48 | -52.33 | -50.28 | -52.63 | -67.72 | -99.15 | -207.87 | -235.53 | -321.66 |
Source: Capital IQ
